Liquidia Corporation (LQDA) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped LQDA stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Liquidia Corporation (LQDA) represents a promising investment opportunity due to its exceptional revenue growth potential and strong market position. The company's recent announcements surrounding partnerships, clinical trial advancements, and strong analyst demand suggest favorable outlooks. Despite competitive pressures and regulatory challenges, Liquidia's innovative pipeline offers long-term growth scalability. The saved 1-year distribution is P10 $50.1, P50 $70.8, and P90 $89.9.
Last analyzed · Model: gpt-4o
Liquidia Corporation Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $50.1 | Pessimistic plausible scenario |
| P50 | $70.8 | Median scenario |
| P90 | $89.9 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Liquidia Corporation's strong analyst consensus and robust fundamentals, including high estimated revenue growth, indicate significant potential for positive price movement. The stock's recent positive headlines, strong Q1 earnings, and partnership developments further bolster this outlook.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this LQDA analysis generated?
May 30, 2026.
Is this a guaranteed LQDA prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full LQDA stock analysis · LQDA sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.